The Lucira Check It test is a molecular, rapid point-of-care test for the detection of SARS-CoV-2 (the causative agent of COVID-19). It is more sensitive than antigen-based POCTs and preliminary data suggest it has a sensitivity approaching that of lab-based PCR tests. The test can be performed with minimal training and at the point of sample collection. The test also provides a fast turn around time (10-30 minutes) allowing the result to be acted on more quickly than RT-PCR. It is to be used in limited settings as approved by Microbiology at Nova Scotia Health and IWK Health Centre, the Covid Network, and Public Health. A positive result must be confirmed with a new swab for PCR. A negative result cannot be used to definitively rule out infection with SARS-CoV-2.
As per the Lucira Competency Checklist, the following information must be reviewed prior to participating in on-the-job training. If you are familiar and regularly use these care directives, policies, and/or perform these procedures, please quickly review and note their application to COVID-19 specimen collection. If these care directives, policies and procedures are unfamiliar or new to you, please review. Once finished your self-directed review, please put initials, date and signature on the Lucira Point-of-Care Rapid Test Competency Checklist.
For a positive POCT test result:
The laboratory can then prioritize the testing appropriately based on local protocols and supply. If a patient is discharged prior to receiving results, the following information can be provided: